Major stock indexes ended higher for a fourth straight session Tuesday, with the S&P 500 setting a fresh closing record, ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Novo Nordisk A/S ADR (NVO), a trailblazer in the weight-loss revolution, has endured a bruising 2025. The Danish pharma giant ...

NEW YORK -- Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The S&P 500 ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

US stocks drifted higher to more records on a holiday-shortened day of trading. The S&P 500 rose 0.3%. The Dow Jones ...

Novo Nordisk A/S is rated a Buy with improved execution and valuation gap with LLY to drive outperformance through 2026. Read ...

European shares ended the holiday-shortened trading week near record highs and on track for their strongest annual ...

Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli ...

In Europe, the Stoxx Europe 600 was flat in morning trading. Novo Nordisk Series B rose 9.2% and SIG Group climbed 5.1%. On the other hand, Frontline lost 3.1%, and Gerresheimer slipped 2.7%. The FTSE ...

A passenger in the GMC Sierra was injured by the air bag. The pickup had an open recall for a defective air bag. Pill Version of Wegovy Is Approved for Use in the U.S. Novo Nordisk said it plans to ...